Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments.
Apr 20, 2023
0
30
A randomized clinical trial is looking at whether fecal microbiota transplantation (FMT) from healthy donors into adults with early-stage amyotrophic lateral sclerosis (ALS—one of the most common forms of motor neuron disease) ...
Apr 17, 2023
0
10
As a deadly disease that people can catch from ticks moves across the continent, the EU is seeking new tests and a vaccine for the infection.
Apr 14, 2023
0
306
A key feature of the severe allergic reaction known as anaphylaxis is an abrupt drop in blood pressure and body temperature, causing people to faint and, if untreated, potentially die.
Mar 17, 2023
0
97
A new study led by Bruno Silva Santos, group leader and vice-director at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal), and published in Cell Reports revealed that a type of white blood cell, the ...
Feb 13, 2023
0
69
People with relatively high levels of lipids in their blood are less likely to develop allergic conditions such as eczema and asthma. These lipids cause genes that play a key role in allergic reactions to be less active. ...
Feb 6, 2023
0
59
A combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progression of the disease in patients. On the other hand, clinical studies show that the combination ...
Jan 30, 2023
0
39
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
Children have largely avoided severe COVID-19 symptoms because they have a strong initial 'innate' immune reaction that quickly defeats the virus. And now, researchers led by scientists at the Garvan Institute of Medical ...
Jan 26, 2023
0
20
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
Jan 2, 2023
0
65
